On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year.
See below for the details.
1- Overall Statistic
It can be seen from Figure 1, 2, 3 and 4, the backlog of drug applications in CDE has been greatly alleviated: the application number waiting in line has dropped from nearly 22,000 at the peak of year 2015 to 3,440 in year 2018; the review completion rate for all types of drug applications in 2018 has exceeded 90%.
2- Statistic of Chemical Drugs -Overall
3- Statistic of Chemical Drugs -IND
4- Statistic of Chemical Drugs -NDA